Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002

Gerlich M, Gschwend P, Uchtenhagen A, Krämer A, Rehm J (2006)
European Journal of Epidemiology 21(7): 545-549.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Gerlich, Miriam; Gschwend, Patrick; Uchtenhagen, Ambros; Krämer, AlexanderUniBi ; Rehm, Juergen
Abstract / Bemerkung
Background: Hepatitis C virus (HCV) remains very prevalent in injection drug users (IDUs). In spite of recommended vaccinations against hepatitis A virus (HAV) and hepatitis B virus (HBV), many IDUs remain susceptible to HAV and HBV. Study population and methods: Patients entering heroin-assisted treatment between 2000 and 2002 (N = 210) were compared for infectious disease status with patients entering this treatment in 1998 (N = 243) and between 1994 and 1996 (N = 1035). Infection status was determined with the aid of questionnaires and blood tests for antibodies against HAV, HBV core antigen, HCV and HIV. Results: In the cohort 2000-2002 78.3% of the patients were HCV positive, 53.3% were HBV positive, 41.2% were HAV positive and 12.6% were HIV positive. In comparison to the cohorts entering the heroin-assisted treatment at an earlier time, there was a significant reduction of HBV and HAV infections, but not of HCV and HIV infections. 15.6% of the patients entering between 2000 and 2002 were vaccinated against HBV and 10.3% against HAV. 31.1% of patients at entrance were susceptible for HBV and 48.5% for HAV. In comparison to patients entering treatment in 1998 there was no significant increase in patients who were vaccinated against HBV. Conclusions: This data illustrates the need for improving HCV prevention and more consequent vaccination against HBV and HAV in IDUs.
Stichworte
hepatitis virus; human immunodeficiency; virus (HIV); vaccination; injection drug use; heroin-assisted treatment
Erscheinungsjahr
2006
Zeitschriftentitel
European Journal of Epidemiology
Band
21
Ausgabe
7
Seite(n)
545-549
ISSN
0393-2990
eISSN
1573-7284
Page URI
https://pub.uni-bielefeld.de/record/1597348

Zitieren

Gerlich M, Gschwend P, Uchtenhagen A, Krämer A, Rehm J. Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002. European Journal of Epidemiology. 2006;21(7):545-549.
Gerlich, M., Gschwend, P., Uchtenhagen, A., Krämer, A., & Rehm, J. (2006). Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002. European Journal of Epidemiology, 21(7), 545-549. https://doi.org/10.1007/s10654-006-9023-z
Gerlich, Miriam, Gschwend, Patrick, Uchtenhagen, Ambros, Krämer, Alexander, and Rehm, Juergen. 2006. “Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002”. European Journal of Epidemiology 21 (7): 545-549.
Gerlich, M., Gschwend, P., Uchtenhagen, A., Krämer, A., and Rehm, J. (2006). Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002. European Journal of Epidemiology 21, 545-549.
Gerlich, M., et al., 2006. Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002. European Journal of Epidemiology, 21(7), p 545-549.
M. Gerlich, et al., “Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002”, European Journal of Epidemiology, vol. 21, 2006, pp. 545-549.
Gerlich, M., Gschwend, P., Uchtenhagen, A., Krämer, A., Rehm, J.: Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002. European Journal of Epidemiology. 21, 545-549 (2006).
Gerlich, Miriam, Gschwend, Patrick, Uchtenhagen, Ambros, Krämer, Alexander, and Rehm, Juergen. “Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002”. European Journal of Epidemiology 21.7 (2006): 545-549.

16 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
Alanko Blomé M, Björkman P, Flamholc L, Jacobsson H, Widell A., Vaccine 35(1), 2017
PMID: 27894721
Let It "B"? The role of Hepatitis B universal vaccination among italian problematic drug users.
Lugoboni F, Pavarin RM, Resentera C, Gambini D., Int J Environ Res Public Health 12(4), 2015
PMID: 25872013
WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs.
Walsh N, Verster A, Rodolph M, Akl EA., Int J Drug Policy 25(3), 2014
PMID: 24561223
Historical epidemiology of hepatitis C virus (HCV) in selected countries.
Bruggmann P, Berg T, Øvrehus AL, Moreno C, Brandão Mello CE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD, Sperl J, Akarca U, Balık I, Bihl F, Bilodeau M, Blasco AJ, Buti M, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Mauss S, Mendes Correa MC, Müllhaupt B, Myers RP, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Rosenberg WM, Sarmento-Castro R, Sarrazin C, Semela D, Shiha GE, Sievert W, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, van Thiel I, Van Vlierberghe H, Vandijck D, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Hindman SJ., J Viral Hepat 21 Suppl 1(), 2014
PMID: 24713004
Reducing the adverse impact of injection drug use in Canada.
Laupland KB, Embil JM., Can J Infect Dis Med Microbiol 23(3), 2012
PMID: 23997772
Deadly public policy: what the future could hold for the HIV epidemic among injection drug users in Vancouver.
O'Shaughnessy MV, Hogg RS, Strathdee SA, Montaner JS., Curr HIV/AIDS Rep 9(4), 2012
PMID: 22773331
Hepatitis A Virus among Drug Users and the Role of Vaccination: A Review.
Lugoboni F, Pajusco B, Albiero A, Quaglio G., Front Psychiatry 2(), 2011
PMID: 22347865
Difficulties with interferon treatment in former intravenous drug users.
Gazdag G, Horváth G, Szabó O, Ungvari GS., Braz J Infect Dis 15(2), 2011
PMID: 21503405
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, Dalgard O, Dillion JF, Flisiak R, Forns X, Frankova S, Goldis A, Goulis I, Halota W, Hunyady B, Lagging M, Largen A, Makara M, Manolakopoulos S, Marcellin P, Marinho RT, Pol S, Poynard T, Puoti M, Sagalova O, Sibbel S, Simon K, Wallace C, Young K, Yurdaydin C, Zuckerman E, Negro F, Zeuzem S., Liver Int 31 Suppl 2(), 2011
PMID: 21651702
Bloodborne viral hepatitis infections among drug users: the role of vaccination.
Lugoboni F, Quaglio G, Civitelli P, Mezzelani P., Int J Environ Res Public Health 6(1), 2009
PMID: 19440291
Seroprevalence of hepatitis A virus infection in persons with HIV infection in Taiwan: implications for hepatitis A vaccination.
Sun HY, Kung HC, Ho YC, Chien YF, Chen MY, Sheng WH, Hsieh SM, Wu CH, Liu WC, Hung CC, Chang SC., Int J Infect Dis 13(5), 2009
PMID: 19208490
The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies.
Luquero FJ, Vallejo F, Fuente Lde L, Toro C, Brugal MT, Bravo MJ, Soriano V, Barrio G, Pulido J, Project Itinere Group., Vaccine 27(20), 2009
PMID: 19428878
[Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
Murcia J, Portilla J, Bedia M, Palazón JM, Sánchez-Payá J, Saiz de la Hoya P, Payá A, Boix V, Merino E, Reus S., Enferm Infecc Microbiol Clin 27(4), 2009
PMID: 19246126
Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports.
Wurst FM, Dürsteler-MacFarland KM, Auwaerter V, Ergovic S, Thon N, Yegles M, Halter C, Weinmann W, Wiesbeck GA., Alcohol Clin Exp Res 32(9), 2008
PMID: 18616663
Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology.
Hendrickx G, Van Herck K, Vorsters A, Wiersma S, Shapiro C, Andrus JK, Ropero AM, Shouval D, Ward W, Van Damme P., J Viral Hepat 15 Suppl 2(), 2008
PMID: 18837827

34 References

Daten bereitgestellt von Europe PubMed Central.

Prevention of spread of hepatitis C.
Alter MJ., Hepatology 36(5 Suppl 1), 2002
PMID: 12407581

E, Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 6(), 2001

PJ, Hepatitis C-Virus-Infektion. Übersicht. Praxis 89(), 2000

GJ, J␣Clinical Virol 26(), 2003

C, J␣Viral Hepat 9(), 2002

M, Eur J Epidemio 18(), 2003

AUTHOR UNKNOWN, 0

R, 2000

M, Sucht 44(6), 1998

F, Rechtsmedizin 9(), 1999
Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?
Hope VD, Judd A, Hickman M, Lamagni T, Hunter G, Stimson GV, Jones S, Donovan L, Parry JV, Gill ON., Am J Public Health 91(1), 2001
PMID: 11189821

A, 2000

JJ, The Can Med Assoc J 165(3), 2001
Hepatitis A among homosexual men and injection drug users: more evidence for vaccination.
Villano SA, Nelson KE, Vlahov D, Purcell RH, Saah AJ, Thomas DL., Clin. Infect. Dis. 25(3), 1997
PMID: 9314468

C, 1999
Predictors of hepatitis B and C infection in injecting drug users both in and out of drug treatment.
Cook PA, McVeigh J, Syed Q, Mutton K, Bellis MA., Addiction 96(12), 2001
PMID: 11784471
Failure to vaccinate current injecting drug users against hepatitis B in England and Wales.
Lamagni TL, Hope VD, Davison KL, Parry JV, Gill ON., Commun Dis Public Health 4(1), 2001
PMID: 11467026

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
Hepatitis A virus infections in injecting drug users.
Crowcroft NS., Commun Dis Public Health 6(2), 2003
PMID: 12889283

AUTHOR UNKNOWN, 0
Characterisation of an epidemic of hepatitis A virus involving intravenous drug abusers--infection by needle sharing?
Grinde B, Stene-Johansen K, Sharma B, Hoel T, Jensenius M, Skaug K., J. Med. Virol. 53(1), 1997
PMID: 9298735
Hepatitis A virus and injecting drug misuse in Aberdeen, Scotland: a case-control study.
Roy K, Howie H, Sweeney C, Parry J, Molyneaux P, Goldberg D, Taylor A., J. Viral Hepat. 11(3), 2004
PMID: 15117332

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

S, 2005
Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?
Hope VD, Judd A, Hickman M, Lamagni T, Hunter G, Stimson GV, Jones S, Donovan L, Parry JV, Gill ON., Am J Public Health 91(1), 2001
PMID: 11189821

G, Drug Alcohol Depend 66(), 2002

RS, J Acquir Immune Defic Syndr Hum Retrovirol 18(Suppl. 1), 1998
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City.
Diaz T, Des Jarlais DC, Vlahov D, Perlis TE, Edwards V, Friedman SR, Rockwell R, Hoover D, Williams IT, Monterroso ER., Am J Public Health 91(1), 2001
PMID: 11189819
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 16858622
PubMed | Europe PMC

Suchen in

Google Scholar